Pediatrics & Neonatology
Volume 50, Issue 5 , Pages 239-244 , October 2009

Early Development of Acute Myeloid Leukemia Following Treatment of Osteosarcoma: A Case Report and Review of the Literature

  • Yu-Mei Shen

      Affiliations

    • Department of Pediatrics, Hsin Chu General Hospital, Hsinchu, Taiwan
  • ,
  • Giun-Yi Hung

      Affiliations

    • Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
    • National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Pediatrics, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan
  • ,
  • Hsiu-Ju Yen

      Affiliations

    • Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
    • National Yang-Ming University School of Medicine, Taipei, Taiwan
  • ,
  • Ming-Yun Hsieh

      Affiliations

    • Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
    • National Yang-Ming University School of Medicine, Taipei, Taiwan
  • ,
  • Te-Kuei Hsieh

      Affiliations

    • Department of Pediatrics, Hsin Chu General Hospital, Hsinchu, Taiwan

Received 14 August 2008 ,Revised 13 January 2009 ,Accepted 14 March 2009.

References 

  1. Franklin J , Pluetschow A , Paus M , et al.   Second malignancy risk associated with treatment of Hodgkin's lymphoma: metaanalysis of the randomised trials . Ann Oncol . 2006;17:1749–1760
  2. Hijiya N , Hudson MM , Lensing S , et al.   Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia . JAMA . 2007;297:1207–1215
  3. Longhi A , Errani C , De Paolis M , Mercuri M , Bacci G . Primary bone osteosarcoma in the pediatric age: state of the art . Cancer Treat Rev . 2006;32:423–436
  4. Bacci G , Ferrari C , Longhi A , et al.   Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy . J Pediatr Hematol Oncol . 2006;28:774–780
  5. Ferrara F , Melillo L , Montillo M , et al.   Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation . Ann Hematol . 1999;78:380–384
  6. He XY , Elson P , Pohlman B , et al.   Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial . BMC Cancer . 2002;2:12
  7. Secker-Walker LM , Stewart EL , Todd A . Acute lymphoblastic leukaemia with t(4;ll) follows neuroblastoma: a late effect of treatment? . Med Pediatr Oncol . 1985;13:48–50
  8. Felix CA . Secondary leukemias induced by topoisomerase-targeted drugs . Biochim Biophys Acta . 1998;1400:233–255
  9. Silva ML , Land MG , Maradei S , et al.   Translocation (11;11) (p13∼p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis . Cancer Genet Cytogenet . 2002;135:101–102
  10. Schoch C , Kern W , Schnittger S , Hiddemann W , Haferlach T . Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML . Leukemia . 2004;18:120–125
  11. Secker-Walker LM , Moorman AV , Bain BJ , et al.   Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities . Leukemia . 1998;12:840–844
  12. Kollmannsberger C , Beyer J , Droz JP , et al.   Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors . J Clin Oncol . 1998;16:3386–3391
  13. Kawai A , Sugihara S , Naito N , et al.   Development of acute myeloid leukemia after chemotherapy for osteosarcoma . Clin Orthop Relat Res . 2001;391:239–246
  14. Jacobs AD , Gale RP . Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma . Cancer Treat Rep . 1984;68:909–911
  15. Kantarjian HM , Keating MJ , Walters RS , et al.   The association of specific “favorable” cytogenetic abnormalities with secondary leukemia . Cancer . 1986;58:924–927
  16. Davies SV , Murray JA , Bowser-Riley SM . Secondary leukemia with a translocation (8;21)? . Cancer Genet Cytogenet . 1988;31:271–274
  17. Whang-Peng J , Young RC , Lee EC , Longo DL , Schechter GP , DeVita VT . Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities . Blood . 1988;71:403–414
  18. Sozzi G , Miozzo M , Orazi A , et al.   Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL) . Br J Cancer . 1990;61:425–428
  19. Kapelushnik J , Dubé I , Wilson P , Greenberg M . Acute lymphoblastic leukemia with t(4;11) translocation after osteogenic sarcoma . Cancer . 1991;67:2887–2889
  20. Pappo A , Schneider NR , Sanders JM , Buchanan GR . Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma . Cancer . 1991;68:1373–1375
  21. Glasser DB , Lane JM , Huvos AG , Marcove RC , Rosen G . Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience . Cancer . 1992;69:698–708
  22. Jeha S , Jaffe N , Robertson R . Secondary acute nonlymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma . Med Pediatr Oncol . 1992;20:71–74
  23. Miniero R , Barisone E , Vivenza C , et al.   Acute lymphoblastic leukemia in a girl treated for osteosarcoma . Pediatr Hematol Oncol . 1995;12:185–188
  24. Minamizaki T , Okuno M , Yamamoto K , et al.   A case of secondary leukemia complicating therapy for osteosarcoma . J Jpn Orthop Assoc . 1996;70(Suppl):959; [In Japanese]
  25. Panizo C , Patino A , Calasanz MJ , Rifon J , Sierrasesumaga L , Rocha E . Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations . Med Pediatr Oncol . 1998;30:165–169
  26. Escudero MC , Lassaletta A , Sevilla J , et al.   Chemotherapy-related secondary acute myeloid leukemia in patients diagnosed with osteosarcoma . J Pediatr Hematol Oncol . 2004;26:454–456
  27. Brichard B , Poirel HA , Chantrain C , et al.   Unusual association of MLL rearrangement and secondary myelomonocytic leukemia in a 15-year-old patient treated for osteosarcoma . Leuk Res . 2007;31:1597–1599
  28. Stine KC , Saylors RL , Sawyer JR , Becton DL . Secondary acute myelogenous leukemia following safe exposure to etoposide . J Clin Oncol . 1997;15:1583–1586
  29. Baer MR , Barcos M , Farrell H , Raza A , Preisler HD . Acute myelogenous leukemia with leukemia cutis eighteen cases seen between 1969 and 1986 . Cancer . 1989;63:2192–2200
  30. Agis H , Weltermann A , Fonatsch C , et al.   A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis . Ann Hematol . 2002;81:90–95
  31. Byrd JC , Edenfield WJ , Shields DJ , Dawson NA . Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review . J Clin Oncol . 1995;13:1800–1816

PII: S1875-9572(09)60070-X

doi: 10.1016/S1875-9572(09)60070-X

Pediatrics & Neonatology
Volume 50, Issue 5 , Pages 239-244 , October 2009